APAC in-Vitro Diagnostics Market to Reach $18.5 Bn by 2024: Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Johnson & Johnson, Siemens and Sorin
Asia Pacific In-vitro Diagnostics Market size was valued at USD 12.3 billion in 2017 and is expected to witness 6.0% CAGR from 2018 to 2024.Increasing prevalence of chronic infections in Asia Pacific countries with poor hygienic conditions will augment demand for diagnostic procedures in forthcoming years.
View full press release